ALLIANCE FOR TOBACCO CESSATION:
OVERVIEW OF THE
CESSATION SUBCOMMITTEE OF THE
INTERAGENCY COMMITTEE ON
SMOKING AND HEALTH
Matt Barry
Senior Policy Analyst
Campaign for Tobacco Free Kids
November 19, 2002
WHAT IS THE INTERAGENCY COMMITTEE ON
SMOKING AND HEALTH (ICSH)?
•
The ICSH was established by Congress on April 19, 1985
under the authority of the Comprehensive Smoking
Education Act for 1984 (P.L. 98-474).
•
According to the statute, the purpose of the ICSH is to:
-
coordinate the research and educational programs of
HHS related to the effect of smoking on human health
with the activities of other government and private
agencies; and
-
establish and maintain a liaison with appropriate private
entities, other government agencies regarding activities
related to the effects of smoking on human health.
WHAT IS THE CESSATION SUBCOMMITTEE
OF THE ICSH?
• Originated out of meeting of full ICSH on cessation
at August 2001 meeting.
• The Cessation Subcommittee is charged with
making recommendations on how best to promote
tobacco use cessation.
• The Subcommittee will develop and submit to the
Secretary of HHS a report that contains action
steps for both a Secretarial initiative and publicprivate partnerships to best promote tobacco use
cessation.
SUBCOMMITTEE MEMBERS
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Chair - Michael Fiore, M.D., M.P.H. (Univ. WI)
Robert T. Croyle, Ph.D. (NCI)
Susan J. Curry, Ph.D. (UI- Chicago)
Charles M. Cutler, M.D., M.S. (AAHP)
Ronald Davis, M.D. (AMA)
Catherine Gordon, R.N., M.B.A. (CMS)
Cheryl Healton, Dr.PH (ALF)
Rosemarie Henson, M.S.S.W, M.P.H. (CDC/OSH)
Howard Koh, M.D., M.P.H., FACP (MA DPH)
James Marks, M.D., M.P.H. (CDC/NCCDPHP)
Tracy Orleans, Ph.D. (RWJF)
Dennis Richling, M.D. (UP Railroad)
David Satcher, M.D. (Morehouse)
John Seffrin, Ph.D. (ACS)
Christine Williams (AHRQ)
Larry N. Williams, DDS, MAGD (USN)
THE EVIDENCE BASE FOR THE SUBCOMMITTEE
•
the PHS Clinical Practice Guideline: Treating Tobacco Use
and Dependence;
•
the U.S. Task Force on Community Preventive Services’
Guide to Community Preventive Services: Tobacco Use
Prevention and Control;
•
the ICSH Action Plan on Tobacco Use Cessation, and
•
the National Blueprint for Disseminating and Implementing
Evidence-Based Clinical and Community Strategies to
Promote Tobacco Use Cessation.
These four documents are related to objectives to promote
tobacco use cessation in four different areas: clinicians,
health care systems, communities and consumers.
KEY SUBCOMMITTEE OBJECTIVES
• Obtain input and support from influential
individuals and organizations regarding
opportunities to promote tobacco use cessation,
barriers to promote cessation, and
recommendations for overcoming those barriers.
• Transmit a report to the Secretary that outlines
specific action steps for HHS to promote tobacco
use cessation and overcome identified barriers
that will be implemented in 2003 and subsequent
years.
PUBLIC HEARINGS
The Subcommittee will hold three public meetings this
fall to obtain input from key audiences on:
• evidence-based opportunities to promote tobacco
use cessation,
• evidence-based strategies to overcome barriers
and challenges faced by your group to ensure
tobacco use cessation is promoted, and
• evidence-based support DHHS could provide to
promote cessation, either through Federal
initiatives or through fostering public-private
partnerships.
TOBACCO CONTROL COMMUNITY’S
RESPONSE TO PUBLIC HEARINGS
•
Emphasize need to be comprehensive, focus on both
population-based (excise taxes, CIA laws) and individual
cessation services (counseling and drugs) in order to increase
demand for services among tobacco users.
•
Need for HHS to demonstrate leadership (begin with coverage
of cessation under Medicaid and Medicare).
•
Need for tobacco control community to show broad support for
cessation - traditional health care groups, groups representing
under-represented populations (low income, racial and ethnic
minorities), smokers, health plans, businesses, and providers.
ROLE OF THE ALLIANCE IN PUBLIC HEARINGS
• Developed a background document on
recommendations organizations could make to
the Subcommittee (copies are available upon
request).
• Information was sent to the tobacco control,
prevention, research and cessation communities
about the hearings in an effort to get more
organizations and individuals to provide
testimony.
THEMES FROM OCTOBER 24 HEARING
IN WASHINGTON, DC
• Comprehensive
• Quitlines with no barriers
• Excise tax increases
• Education of health care professionals
• FDA product regulation
• HHS to lead by example
• Need for more research
GROUPS/VOICES NOT YET HEARD BUT
NEEDED TO SPEAK/SUBMIT TESTIMONY











Business leaders
Purchasers and Insurers
Elected officials
Community service organizations
Representatives from diverse, affected populations
Smokers
Senior citizens
Military/VA
Health care delivery systems
Safety net providers
Medicaid agencies
LOCATION OF PUBLIC HEARINGS
October 24 - Washington, DC
November 14 - Denver, CO
December 3 - Chicago, IL
You can also submit written comments to
CDC/OSH until December 20, 2002.
FOR MORE INFORMATION ON THE
SUBCOMMITTEE
Visit http://www.cdc.gov/tobacco/ICSH/subcommittee.htm
or
If you would like to attend and/or speak at the public
meetings, and/or submit written comments for the
record, contact Jessica Porras of CDC/OSH by
phone (202-205-8500), fax (202-205-8313) or email
(jporras@cdc.gov).